[go: up one dir, main page]

MX2010005276A - Proceso de esterilizacion por filtracion en estado diluido para biopolimeros viscoelasticos. - Google Patents

Proceso de esterilizacion por filtracion en estado diluido para biopolimeros viscoelasticos.

Info

Publication number
MX2010005276A
MX2010005276A MX2010005276A MX2010005276A MX2010005276A MX 2010005276 A MX2010005276 A MX 2010005276A MX 2010005276 A MX2010005276 A MX 2010005276A MX 2010005276 A MX2010005276 A MX 2010005276A MX 2010005276 A MX2010005276 A MX 2010005276A
Authority
MX
Mexico
Prior art keywords
biopolymers
viscoelastic
dilute
sterilization process
biopolymer
Prior art date
Application number
MX2010005276A
Other languages
English (en)
Other versions
MX338879B (es
Inventor
Menakem Fuchs
Dror Eyal
Yehuda Zelig
Original Assignee
Bio Technology General Israel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Israel filed Critical Bio Technology General Israel
Publication of MX2010005276A publication Critical patent/MX2010005276A/es
Publication of MX338879B publication Critical patent/MX338879B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Sustainable Development (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Los productos manufacturados de ácido hialurónico se utilizan en numerosas aplicaciones quirúrgicas que incluyen la complementación viscoelástica para el tratamiento de la osteoartritis, sin embargo, las técnicas de esterilización tradicionales dan por resultado la descomposición de estos biopolímeros viscoelásticos de alto peso molecular y de esta manera son inadecuadas. Se dan a conocer procesos para obtener soluciones estériles, concentradas de biopolímeros de alto peso molecular tal como el ácido hialurónico. Los procesos incluyen la esterilización por filtración con una preparación diluida del biopolímero y la concentración del biopolímero esterilizado por filtración, diluido mediante la ultrafiltración hasta una concentración deseada.
MX2010005276A 2007-11-13 2008-11-12 Proceso de esterilizacion por filtracion en estado diluido para biopolimeros viscoelasticos. MX338879B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07120568 2007-11-13
PCT/IB2008/003042 WO2009063291A1 (en) 2007-11-13 2008-11-12 Dilute filtration sterilization process for viscoelastic biopolymers

Publications (2)

Publication Number Publication Date
MX2010005276A true MX2010005276A (es) 2010-08-31
MX338879B MX338879B (es) 2016-05-04

Family

ID=39060256

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005276A MX338879B (es) 2007-11-13 2008-11-12 Proceso de esterilizacion por filtracion en estado diluido para biopolimeros viscoelasticos.

Country Status (14)

Country Link
US (3) US20110130473A1 (es)
EP (1) EP2209814B1 (es)
JP (1) JP2011503047A (es)
KR (1) KR20100094982A (es)
CN (1) CN101855248B (es)
AU (1) AU2008322629B2 (es)
CA (1) CA2705850C (es)
ES (1) ES2622834T3 (es)
IL (1) IL205402A (es)
MX (1) MX338879B (es)
NZ (1) NZ584919A (es)
PL (1) PL2209814T3 (es)
RU (1) RU2501811C2 (es)
WO (1) WO2009063291A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101855248B (zh) 2007-11-13 2012-08-22 生物技术通用（以色列）有限公司 用于粘弹性生物聚合物的稀释过滤灭菌方法
ES2762864T3 (es) * 2008-06-18 2020-05-26 Oxford Biomedica Ltd Purificación de virus
US8283463B2 (en) * 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
JP2011195607A (ja) * 2010-03-17 2011-10-06 Denki Kagaku Kogyo Kk ヒアルロン酸及び／又はその塩の精製法
JP2011195608A (ja) * 2010-03-17 2011-10-06 Denki Kagaku Kogyo Kk ヒアルロン酸及び／又はその塩の精製法
JP2011195611A (ja) * 2010-03-17 2011-10-06 Denki Kagaku Kogyo Kk ヒアルロン酸及び／又はその塩の精製法
JP2011195604A (ja) * 2010-03-17 2011-10-06 Denki Kagaku Kogyo Kk ヒアルロン酸及び／又はその塩の含有液中の異物除去方法
CN102492051B (zh) * 2011-12-13 2013-08-28 中南大学 玉竹的深加工及综合利用工艺
TWI424007B (zh) 2011-12-22 2014-01-21 Ind Tech Res Inst 使膠體交聯的方法與藉由此方法形成之經交聯的膠體
KR20220028153A (ko) * 2012-01-20 2022-03-08 임무노포토닉스 인코퍼레이티드 키토산 유래 조성물
CN102978257B (zh) * 2012-12-20 2014-12-10 江苏久吾高科技股份有限公司 一种右旋糖酐的生产方法
US10519419B2 (en) * 2014-01-23 2019-12-31 Nissan Chemical Corporation Method for producing culture medium composition
CN104193850A (zh) * 2014-08-16 2014-12-10 厦门世达膜科技有限公司 一种肝素钠粗品的生产方法
CN104804105B (zh) * 2015-04-08 2018-04-27 成都郫县新星成明食品研究所 采用陶瓷膜过滤法制备卡拉胶的方法
MX383146B (es) 2017-01-11 2025-03-13 Ferring Bv Composición farmacéutica de disgregación rápida.
TWI837085B (zh) * 2017-03-07 2024-04-01 日商持田製藥股份有限公司 海藻酸液劑
WO2020016820A1 (en) 2018-07-18 2020-01-23 Bio-Technology General (Israel) Ltd. Process of, and arrangement for, sterile filtering a non-newtonian liquid and formulation of a liquid obtainable thereby
CN110760015B (zh) * 2019-11-19 2022-07-22 河北鑫合生物化工有限公司 改进的三赞胶的提取方法
WO2023219171A1 (ja) * 2022-05-13 2023-11-16 合同会社Kortuc Japan 高粘性溶液の滅菌化・無菌化法
WO2025088072A1 (en) 2023-10-25 2025-05-01 Ferring B.V. Compositions comprising progesterone and uses thereof

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
DE3244214A1 (de) * 1982-11-30 1984-05-30 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur reinigung und fraktionierung von heparin
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
US5316926A (en) * 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
FR2569724B1 (fr) 1984-09-04 1991-02-08 Chisso Corp Procede pour la preparation d'acide hyaluronique
US4780414A (en) * 1985-01-18 1988-10-25 Bio-Technology General Corp. Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus
US4784990A (en) * 1985-01-18 1988-11-15 Bio-Technology General Corporation High molecular weight sodium hyaluronate
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US5099013A (en) * 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
AU600483B2 (en) * 1986-03-14 1990-08-16 Bio-Technology General Corporation Heavy metal salts of hyaluronic acid
US5023175A (en) * 1986-05-01 1991-06-11 Kabushiki Kaisha Yakult Honsha Novel production process of hyaluronic acid and bacterium strain therefor
JPS6394988A (ja) * 1986-10-08 1988-04-26 Meiji Seika Kaisha Ltd ヒアルロン酸の製造法
JPS6394988U (es) 1986-12-04 1988-06-18
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
FR2620130B1 (fr) * 1987-09-08 1990-01-12 Lipha Nouveaux polysaccharides hydrosolubles, leur procede d'obtention, leur application a titre de medicaments et preparation les renfermant
US5017751A (en) * 1990-06-21 1991-05-21 Gte Laboratories Incorporated Inductively-coupled RF plasma torch
US5213964A (en) * 1990-07-16 1993-05-25 Cholestech Corporation High-density lipoprotein solid-base precipitation assay method
FR2668163B1 (fr) * 1990-10-18 1993-01-15 Orsan Procede de fabrication de beta-cyclodextrine.
JPH0630605B2 (ja) * 1990-10-23 1994-04-27 チッソ株式会社 ヒアルロン酸ナトリウム水溶液の製造法
GB9024223D0 (en) * 1990-11-07 1990-12-19 Fermentech Ltd Production of hyaluronic acid
IT1247175B (it) * 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
AU3065192A (en) * 1991-12-20 1993-07-28 Howmedica Inc. Ultra-pure polysaccharide materials for medical use
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate
IT1263393B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
IT1268954B1 (it) 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Processo per la preparazione di acido ialuronico mediante sintesienzimatica e relative composizioni farmaceutiche
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US6017901A (en) * 1995-05-10 2000-01-25 Fidia Advanced Bioplymers S.R.L. Heavy metal salts of succinic acid hemiesters with hyaluronic acid or hyaluronic acid esters, a process for their preparation and relative pharmaceutical compositions
IT1282219B1 (it) * 1995-12-20 1998-03-16 Fidia Advanced Biopolymers Srl Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US6602693B1 (en) * 1996-07-03 2003-08-05 Clear Solutions Biotech, Inc. Gene encoding hyaluronan synthase
IT1287698B1 (it) 1996-08-29 1998-08-18 Fidia Advanced Biopolymers Srl Fili da sutura essenzialmente costituiti da derivati esterei dello acido ialuronico
DE69723577T2 (de) * 1996-12-27 2004-05-13 Kao Corp. Reinigungsverfahren ionischer polymeren
DK0971961T3 (da) 1997-04-04 2003-03-24 Fidia Advanced Biopolymers Srl N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling
WO1999017821A1 (en) * 1997-10-07 1999-04-15 Bio-Technology General Corp. Device for administration of viscoelastic substance
FR2785910B1 (fr) * 1998-11-16 2002-06-07 Aquamer Procede d'obtention, a partir du milieu de culture de micro-algues, d'un extrait thermostable possedant une activite anti-oxydante et pro-cicatrisante
CA2318356A1 (en) 1998-12-23 2000-07-06 Norbert Presselt Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin
CH692919A5 (fr) * 1999-01-28 2002-12-13 Trb Chemedica S A Procédé de purification de l'acide hyaluronique à poids moléculaire élevé.
IT1306643B1 (it) * 1999-04-08 2001-10-02 Fidia Advanced Biopolymers Srl Processo per la preparazione dei composti autoreticolati dell'acidoialuronico e dei suoi derivati ottenibili mediante la tecnica
EP1223990B1 (en) 1999-10-15 2004-07-28 Genetics Institute, LLC Formulations of hyaluronic acid for delivery of osteogenic proteins
US7166733B2 (en) * 2000-01-04 2007-01-23 Access Pharmaceuticals, Inc. O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes
KR100729015B1 (ko) * 2000-01-04 2007-06-14 어섹스 팔마큐티칼스 인코포레이티드 Ｎ,ｏ-아미도말로네이트 백금 착화합물
US6383344B1 (en) * 2000-07-19 2002-05-07 Genzyme Corporation Molecular weight reduction of polymer using irradiation treatment
US6660853B2 (en) * 2000-12-15 2003-12-09 Al Prescott Method for purifying high molecular weight hyaluronic acid
WO2004014399A1 (en) 2002-08-07 2004-02-19 Laboratoire Medidom S.A. Process for preparing a sterile high molecular weight hyaluronic acid formulation
RU2280041C1 (ru) * 2005-04-21 2006-07-20 Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия ЛТД" Способ получения водорастворимых солевых комплексов гиалуроновой кислоты (варианты)
EP1976857A4 (en) * 2006-01-13 2011-08-03 Baxter Int PROCESS FOR CLEANING POLYSACCHARIDES
CN101855248B (zh) 2007-11-13 2012-08-22 生物技术通用（以色列）有限公司 用于粘弹性生物聚合物的稀释过滤灭菌方法

Also Published As

Publication number Publication date
IL205402A (en) 2015-10-29
ES2622834T3 (es) 2017-07-07
RU2010118163A (ru) 2011-12-20
CA2705850A1 (en) 2009-05-22
RU2501811C2 (ru) 2013-12-20
KR20100094982A (ko) 2010-08-27
EP2209814B1 (en) 2017-01-25
MX338879B (es) 2016-05-04
US20180142041A1 (en) 2018-05-24
CA2705850C (en) 2016-07-19
WO2009063291A1 (en) 2009-05-22
PL2209814T3 (pl) 2017-08-31
AU2008322629A1 (en) 2009-05-22
JP2011503047A (ja) 2011-01-27
US9896518B2 (en) 2018-02-20
EP2209814A1 (en) 2010-07-28
US20110130473A1 (en) 2011-06-02
CN101855248B (zh) 2012-08-22
WO2009063291A8 (en) 2009-09-17
US20140018315A1 (en) 2014-01-16
IL205402A0 (en) 2010-12-30
NZ584919A (en) 2012-05-25
CN101855248A (zh) 2010-10-06
AU2008322629B2 (en) 2013-05-16

Similar Documents

Publication Publication Date Title
MX2010005276A (es) Proceso de esterilizacion por filtracion en estado diluido para biopolimeros viscoelasticos.
ATE420116T1 (de) Verfahren zur herstellung von cellulosesulfat mit verbesserten eigenschaften
CN103965372B (zh) 一种壳聚糖-没食子酸接枝共聚物的制备方法
WO2009005790A3 (en) Sterile thiol-derivatized hyaluronic acid polymer compositions and uses thereof
AR076607A1 (es) Composicion acuosa. metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo
WO2007006403A3 (en) Biomaterials in the form of fibres for use as medical devices in the treatment of wounds, and their production process
EP2783573A3 (en) Long shelf life milk and milk-related products, and a process and milk processing plant for their manufacture
MX336757B (es) Metodo para la produccion de la composicion de acido hipocloroso y aplicaciones.
HRP20140981T2 (hr) Viskoelastični gelovi kao nova punila
CN103819577B (zh) 一种螺旋藻多糖的制备方法
CL2011002021A1 (es) Procedimiento de preparacion de una composicion enriquecida en compuestos fenolicos con una masa molecular inferior a 400 da, a partir de aguas de vegetacion de aceitunas, que comprende clarificacion de dichas aguas, ultrafiltracion tangencial de las aguas de vegetacion clarificadas, nanofiltracion del permeado, adsorcion de los compuestos fenolicos y concentracion.
JP2018168263A (ja) 植物性プロテオグリカン及びその用途
PH12019501469A1 (en) Compositions and methods for treating biofilms
KR20190101425A (ko) 오존을 이용한 다당류 분해 방법
JO2798B1 (en) (Oxazolidinone-5-yl-methyl) -2-Thiophene-carboxamides substituted and used in blood clotting
Michael et al. Marine polysaccharides: Properties and applications
BR102015003197A8 (pt) processo de produção em escala de hidrogel de celulose bacteriana purificada obtida pela polimerização da glicose a partir de açúcares de fontes renováveis via biotecnologia por meio da propagação de bactérias produtoras de celulose particularmente gluconoacetobacter hansenii lmspe, em reatores para aplicação nas áreas de saúde, farmacotécnica e cosmiatria
HK1142916A (en) Dilute filtration sterilization process for viscoelastic biopolymers
ZA200908583B (en) Substituted (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides and use thereof in the field of blood coagulation
CN104367507A (zh) 一种皮肤护理液及其制备方法
CN102604132A (zh) 电子束辐射交联壳聚糖的方法
FR2968004B1 (fr) Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines.
CN102803298B (zh) 透明质酸的提纯方法
BR112014005221A2 (pt) uso de materiais de fibra oca modificada para a remoção de exotoxinas produzidas por escherichia coli a partir de liquidos, de preferência a partir de sangue e de plasma, bem como seu uso para o tratamento de doenças concomitantes
CN107637596A (zh) 一种南瓜种子消毒剂

Legal Events

Date Code Title Description
FG Grant or registration